Evidence map›Paper›PMID 31953912›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti-pertussis Vaccine.

Peng Wang, Chang-Xin Huo, Shuyao Lang, Kyle Caution, Setare Tahmasebi Nick, Purnima Dubey, Rajendar Deora, Xuefei Huang

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Stereoselective Synthesis of Sialyl LewisAngewandte Chemie (International ed. in English) · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Peng WangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI, 48824, USA.
Chang-Xin HuoDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI, 48824, USA.
Shuyao LangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI, 48824, USA.
Kyle CautionDepartment of Microbial Infection and Immunity, The Ohio State University, 460 W 12th Ave, Columbus, OH, 43210, USA.
Setare Tahmasebi NickDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI, 48824, USA.
Purnima DubeyDepartment of Microbial Infection and Immunity, The Ohio State University, 460 W 12th Ave, Columbus, OH, 43210, USA.
Rajendar DeoraDepartment of Microbial Infection and Immunity, The Ohio State University, 460 W 12th Ave, Columbus, OH, 43210, USA.
Xuefei HuangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI, 48824, USA.ORCID 0000-0002-6468-5526
Michigan State University · USThe Ohio State University · USQuantitative BioSciences · US

Funding

Generation of active immunity against cytotoxic oligomeric tau speciesR01CA225105 · NCI · MICHIGAN STATE UNIVERSITY · PI HUANG, XUEFEI · 2018 to 2023
$2.8M
Enhancing efficacy of pertussis vaccinesR01AI125560 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DEORA, RAJENDAR K, DUBEY, PURNIMA · 2016 to 2020
$1.9M
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccinesR01AI146210 · NIAID · MICHIGAN STATE UNIVERSITY · PI HUANG, XUEFEI · 2019 to 2023
$1.5M
NCI NIH HHS R01 CA225105NIAID NIH HHS R01 AI125560NIAID NIH HHS R01 AI146210
6 · The paper itself

Abstract

With the infection rate of Bordetella pertussis at a 60-year high, there is an urgent need for new anti-pertussis vaccines. The lipopolysaccharide (LPS) of B. pertussis is an attractive antigen for vaccine development. With the presence of multiple rare sugars and unusual glycosyl linkages, the B. pertussis LPS is a highly challenging synthetic target. In this work, aided by molecular dynamics simulation and modeling, a pertussis-LPS-like pentasaccharide was chemically synthesized for the first time. The pentasaccharide was conjugated with a powerful carrier, bacteriophage Qβ, as a vaccine candidate. Immunization of mice with the conjugate induced robust anti-glycan IgG responses with IgG titers reaching several million enzyme-linked immunosorbent assay (ELISA) units. The antibodies generated were long lasting and boostable and could recognize multiple clinical strains of B. pertussis, highlighting the potential of Qβ-glycan as a new anti-pertussis vaccine.

Indexed as

AnimalsCattleEnzyme-Linked Immunosorbent AssayFucoseHemocyaninsImmunoglobulin GLipopolysaccharidesMiceOligosaccharidesPertussis VaccineSerum Albumin, BovineFucoseHemocyaninsImmunoglobulin Gkeyhole-limpet hemocyaninLipopolysaccharidesOligosaccharidesPertussis VaccineSerum Albumin, Bovinebacteriophage Qβlipo-oligosaccharidespertussissynthesisvaccines

Identifiers

PMID31953912
PMCPMC7141973
OpenAlexW2999169037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.